MedTrace Logo

Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

NCT06994377 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-25

No results posted yet for this study

Summary

Few data about the impact of emotional distress (ED) on treatment efficacy in patients with metastatic breast cancer (mBC) are available.

Aim of this study is to assess the outcomes of patients with mBC receiving first-line treatment according to the presence of baseline ED.

Conditions

Interventions

BEHAVIORAL

ED and quality of life assessment

Patients will undergo ED and quality of life assessments through specific questionnaires completion

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Gabriella Pravettoni, MD, PhD · European Istitute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-25
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06994377 on ClinicalTrials.gov